EW - Edwards Lifesciences Corporation

NYSE - Nasdaq Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
5,382,400
5,382,400
5,232,500
4,386,300
4,348,000
Cost of revenue
1,080,400
1,080,400
1,248,900
1,080,600
1,114,400
Gross profit
4,302,000
4,302,000
3,983,600
3,305,700
3,233,600
Operating expenses
Research development
945,200
945,200
903,100
760,700
752,700
Selling general and administrative
1,567,600
1,567,600
1,493,700
1,228,400
1,242,200
Total operating expenses
2,512,800
2,512,800
2,396,800
1,989,100
1,994,900
Operating income or loss
1,789,200
1,789,200
1,586,800
1,316,600
1,238,700
Interest expense
19,200
19,200
18,400
15,800
20,700
Total other income/expenses net
-38,100
-38,100
116,200
-407,500
-83,700
Income before tax
1,767,400
1,767,400
1,702,000
916,700
1,166,500
Income tax expense
245,500
245,500
198,900
93,300
119,600
Income from continuing operations
1,521,900
1,521,900
1,503,100
823,400
1,046,900
Net income
1,521,900
1,521,900
1,503,100
823,400
1,046,900
Net income available to common shareholders
1,521,900
1,521,900
1,503,100
823,400
1,046,900
Basic EPS
-
2.46
2.41
1.32
1.68
Diluted EPS
-
2.44
2.38
1.30
1.64
Basic average shares
-
619,000
623,300
622,600
624,800
Diluted average shares
-
624,200
631,200
631,900
636,700
EBITDA
-
1,789,200
1,586,800
1,316,600
1,238,700